DEF: Valuence Merger Corp. I Seeks Another Extension

Valuence Merger Corp. I is seeking shareholder approval to extend its deadline to complete a business combination until March 3, 2027, requiring further sponsor contributions.

Summary

• An Extraordinary General Meeting is scheduled for February 27, 2026, to vote on two proposals: the Extension Amendment Proposal and the Adjournment Proposal.
• The Extension Amendment Proposal seeks to amend the company's charter to extend the deadline for consummating a business combination from March 3, 2026, to May 3, 2026, with the option for up to ten additional one-month extensions, pushing the final deadline to March 3, 2027.
• For each extension, VMCA Sponsor, LLC or its designees must deposit funds into the Trust Account: $56,000 (or $0.06 per public share) for the initial two-month extension and $28,000 (or $0.03 per public share) for each subsequent one-month extension, with a maximum aggregate of $336,000 under the new extension.
• These sponsor contributions are non-interest bearing, unsecured convertible promissory notes, repayable upon a business combination or convertible into warrants of the post-business combination entity at $1.50 per warrant.
• If the Extension Amendment Proposal is not approved, the company will be forced to liquidate, redeeming public shares at an estimated per-share price of approximately $12.47 (based on the Trust Account balance as of January 31, 2026).
• Public shareholders have the right to redeem their shares for cash at this estimated price, with a deadline of 5:00 PM ET on February 25, 2026.
• The company's securities were delisted from Nasdaq on March 11, 2025, due to its failure to complete a business combination within 36 months of its IPO, and now trade on the OTC Pink tier under symbols VMCUF, VMCAF, and VMCWF.
• Insiders (Sponsor, directors, officers) collectively own approximately 75% (5,502,490) of the company's issued and outstanding Ordinary Shares, enabling them to approve both proposals even without public shareholder votes.
• The Trust Account held approximately $23.3 million as of January 31, 2026.
• Previous extensions include an 'Initial Extension' from June 3, 2023, to March 3, 2025, and a 'Prior Extension' from June 3, 2024, to March 3, 2026, which involved aggregate sponsor contributions of $588,231.
• Significant redemptions occurred during prior extensions: 15,799,245 public shares during the Initial Extension and 4,343,316 public shares during the Prior Extension, leaving 1,867,402 public shares outstanding.
• The company is currently engaged in non-binding discussions with a potential target for a Business Combination.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a highly negative development, reflecting persistent operational challenges and a significant loss of market standing, despite management's efforts to secure an extension.

Positives

• The Board unanimously recommends approval of the extension, indicating a continued commitment to finding a business combination.
• The company is actively engaged in non-binding discussions with a potential target, suggesting ongoing efforts to complete a transaction.
• The company has agreed to waive its right to withdraw up to $100,000 of interest accrued on the Trust Account for dissolution expenses, which would increase the amount available to public shareholders upon liquidation.

Negatives

• This is the third request for an extension, indicating persistent difficulty in identifying and completing a business combination.
• The company's securities were delisted from Nasdaq on March 11, 2025, and now trade on the less liquid OTC Pink tier, which can adversely affect trading price and investor ability to transact.
• The Class A Ordinary Shares may be deemed a 'penny stock' due to the delisting, subjecting brokers to more stringent rules and potentially reducing trading activity.
• Previous extensions resulted in substantial redemptions of public shares (over 80% in the Initial Extension and over 70% in the Prior Extension), reflecting a significant loss of public shareholder confidence.
• The estimated per-share redemption price of $12.47 is currently $0.23 less than the closing market price of $12.70 on January 30, 2026, meaning shareholders redeeming now would receive less than if they sold on the open market, though liquidity is a concern.
• The Sponsor and Insiders' 75% ownership of Ordinary Shares means they can approve the proposals regardless of public shareholder votes, potentially prioritizing their interests over those of public shareholders.
• Warrants will become worthless if the company fails to complete a business combination by the applicable deadline.
• The company may be subject to a 1% U.S. federal excise tax on stock buybacks if it becomes a covered corporation, which could reduce cash available for a business combination or future operations.

Risks

• There is no assurance that the new extension will enable the company to complete a Business Combination.
• The company's ability to consummate any Business Combination is dependent on a variety of factors, many of which are beyond its control.
• Even if the new extension is approved, redemptions could leave the company with insufficient cash to consummate a Business Combination on commercially acceptable terms, or at all.
• Shareholders may be unable to recover their investment except through sales of the company's shares on the open market, and the price of securities may be volatile with no assurance of favorable disposal prices.
• Delisting from Nasdaq limits investors' ability to make transactions in the company's securities and subjects it to additional trading restrictions.
• A Business Combination with a U.S. target company may be impacted if subject to U.S. foreign investment regulations and review by a U.S. government entity, such as CFIUS, and could ultimately be prohibited or delayed.
• The company risks being deemed an investment company under the Investment Company Act, which could impose burdensome compliance requirements, restrict activities, and make it difficult to complete a business combination or force liquidation.
• The 1% U.S. federal excise tax on stock buybacks could be imposed on redemptions of the company's stock if it were to become a covered corporation in the future, potentially reducing cash available for a business combination or future operations.

Future Outlook

The company is currently engaged in non-binding discussions with a potential target for a Business Combination and has entered into a non-binding letter of intent. Management believes that extending the deadline will provide additional time to pursue a potential transaction that could create value for shareholders. However, there is no assurance that these discussions will result in a definitive agreement or the consummation of a Business Combination.

Management Comments

• The Board believes that it is in the best interests of the Company's shareholders to adopt the Extension Amendment Proposal in order for the Company to have additional time to complete an initial Business Combination.
• The Company is currently engaged in discussions with a potential target for a Business Combination and has entered into a non-binding letter of intent with such target.
• While there can be no assurance that these discussions will result in a definitive agreement or consummation of a Business Combination, the Company believes that extending the Deadline Date will provide additional time to pursue a potential transaction that could create value for shareholders.

Industry Context

StockSavvy.ai notes that repeated extensions are common for SPACs struggling to identify and close a suitable business combination within their initial timeframe. The delisting from Nasdaq to OTC Pink is a significant negative indicator, often associated with reduced investor interest and liquidity challenges, making it harder for the SPAC to attract a high-quality target or secure additional financing. The substantial insider ownership (75%) and their ability to approve the extension despite public shareholder sentiment highlight a common governance dynamic in SPACs where sponsor interests can diverge from those of public shareholders, especially as the liquidation deadline approaches.

Comparison to Industry Standards

• The company's repeated need for extensions (this being the third major extension request) significantly underperforms the typical SPAC lifecycle, which aims for a business combination within 18-24 months of IPO.
• The delisting from Nasdaq to the OTC Pink tier is a severe negative deviation from industry standards, as most successful SPACs either complete a de-SPAC transaction on a major exchange or liquidate. This move places the company in a less liquid and less transparent market compared to peers that successfully merged and remained listed on NYSE or Nasdaq.
• The high redemption rates in previous extensions (over 80% of public shares redeemed in the Initial Extension, and over 70% in the Prior Extension) are substantially higher than the average redemption rates seen in successful SPAC mergers, indicating a significant lack of confidence from public shareholders in the company's ability to find a suitable target.
• The estimated redemption price of $12.47, while above the initial IPO price of $10.00, is only marginally higher than the current OTC market price of $12.70, offering little incentive for non-redeeming shareholders given the prolonged uncertainty and market illiquidity.

Corporate Governance

Related Party Transactions

• VMCA Sponsor, LLC (the Sponsor) and Valuence Partners LP (an investment fund affiliated with the Sponsor) hold 6,666,667 private placement warrants.
• The Sponsor or its designees will deposit funds into the Trust Account as loans for extensions, which may be converted into warrants of the post-business combination entity.
• Insiders (Sponsor, directors, officers) own 5,502,490 Ordinary Shares (approximately 75%) and have waived liquidation rights with respect to these founder shares.
• Insiders are entitled to reimbursement of out-of-pocket expenses incurred related to identifying, investigating, negotiating, and completing a Business Combination, and repayment of outstanding loans, including the contributions.

Stakeholder Impact

• Shareholders: Public shareholders face continued uncertainty regarding a business combination, potential for further dilution if redemptions are high, and the risk of warrants becoming worthless. Those who redeem may receive slightly less than the current market price, while those who don't retain voting and redemption rights for a future business combination.
• Sponsor/Insiders: Have a significant financial incentive (approximately $14.8 million investment at risk) to complete a business combination to avoid liquidation. They bear the cost of extensions through contributions and maintain control over the extension vote due to their 75% ownership.
• Creditors: The company's obligations under Cayman Islands law to provide for claims of creditors would apply in the event of liquidation.

Next Steps

• Shareholders will vote on the Extension Amendment Proposal and the Adjournment Proposal at the Extraordinary General Meeting on February 27, 2026.
• If the Extension Amendment Proposal is approved, the company will file special resolutions approving the charter amendment with the Cayman Islands Registrar of Companies.
• If the Extension Amendment Proposal is approved, the Board may elect to extend the deadline monthly, requiring corresponding sponsor contributions.
• The company will continue its efforts to identify and consummate a Business Combination on or before the applicable Deadline Date.
• Voting results will be announced at the Extraordinary General Meeting and disclosed in a Current Report on Form 8-K filed with the SEC within four business days.
• An extraordinary general meeting will be held at a future date to approve any potential Business Combination and related transactions.

Key Dates

Recommendation

The company's repeated failures to secure a business combination, coupled with its delisting from Nasdaq and subsequent trading on the illiquid OTC Pink market, signal severe operational distress and a high probability of eventual liquidation. While the extension provides a slim chance for a deal, the historical high redemption rates and the current market price being only marginally above the redemption value, combined with the risk of warrants becoming worthless, suggest that public shareholders should consider exiting to preserve capital, especially given the lack of liquidity on the OTC market. The significant insider control over the vote further diminishes public shareholder influence.

Keywords

SPAC, Special Purpose Acquisition Company, Extension, Business Combination, Merger, Acquisition, Liquidation, Redemption, Trust Account, Nasdaq Delisting, OTC Market, Shareholder Vote, Proxy Statement, Valuence Merger Corp. I, VMCA Sponsor LLC, Corporate Governance, Risk Factors, SEC Filing